- Date: 14 April 2027
- Location: MEB
A pipeline meeting is a session where the MEB engages with a company to discuss new innovations and plans in the area of drug development for the upcoming period. The primary focus is on the general aspects of the company's product portfolio.
Planned meeting: Wednesday, April 14, 2027.
Topic: Open call
Companies can apply for this pipeline meeting to present products in their pipeline and elaborate on the challenges they face and how they wish or have addressed them. Companies are requested to clearly specify the topics they wish to discuss.
Depending on the topics to be discussed, the CCMO will participate in the pipeline meeting.
Registration deadline: Friday, December 11, 2026.
After the registration deadline, the MEB will select a maximum of three companies from the submissions. The selected companies will be informed via email about their scheduled pipeline meeting. Companies that are not selected will receive a rejection notice via email. Companies will be notified whether they have been selected or not within 3 weeks of the application deadline.
If a pharmaceutical company is selected to participate in a specific pipeline meeting, we ask the company to provide a briefing document to help the MEB participants prepare for the meeting. This briefing document should be submitted no later than Friday, March 12, 2027.